UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000011806
Receipt number R000013805
Scientific Title Randomized phase II study of Gemcitabine and S-1 combination therapy versus S-1 in patients with Gemcitabine-refractory unresectable advanced Pancreatic Cancer
Date of disclosure of the study information 2013/09/19
Last modified on 2019/03/29 10:30:20

No. Disposal Last modified on Item of update
1 Insert 2013/09/19 13:17:49
2 Update 2015/03/20 14:38:21 Key inclusion criteria
Key inclusion criteria
3 Update 2015/09/20 16:02:55


Key inclusion criteria
4 Update 2017/03/24 10:42:23 Name of primary person or sponsor
Organization
Organization
5 Update 2019/03/29 10:26:11 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Organization
Address
Address
Tel
Email
6 Update 2019/03/29 10:29:19 Recruitment status
Date of IRB
Last follow-up date
7 Update 2019/03/29 10:30:20 Number of participants that the trial has enrolled